Larvol Delta - BCA101X301-A-trial-to-see-if-ficerafusp-alfa-given-with-pembrolizumab-can-treat-participants-with-head-and-neck-cancer

ficerafusp alfa (BCA101) - Bicara Therapeutics

Keytruda (pembrolizumab) - Merck (MSD)

https://euclinicaltrials.eu/ctis-public/view/2024-519654-37-00

Feb 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next